Articles tagged with Psychiatrist
Showing 3 of 3 articles
New Zealand Approves Psychiatrists to Prescribe MDMA for PTSD Treatment
03 Sep 2026 | 5 days ago | 156 viewsAssociate Health Minister David Seymour welcomes Medsafe’s approval for two psychiatrists to prescribe pharmaceutical grade MDMA for treating PTSD through psychedelic-assisted therapy, aligning New Zealand with Australia’s clinical practices. MDMA remains unapproved as a medicine, but strict safeguards and comprehensive clinical assessments ensure its safe and appropriate use within a controlled therapeutic setting, with no take-home dispensing allowed. This approval is specific to the two psychiatrists, requiring other clinicians to obtain separate Medsafe authorization, reflecting a commitment to expanding access to innovative treatments responsibly.
Tags: David Seymour Medsafe MDMA PTSD psychiatrists New Zealand Australia pharmaceutical grade clinical assessmentNew ADHD Treatment Access in New Zealand Expanded to GPs and Nurse Practitioners
31 Jan 2026 | 7 months ago | 1077 viewsNew Zealand has expanded who can assess, diagnose, and start treatment for ADHD to improve timely access, allowing specialist GPs and nurse practitioners to manage adults and certain nurse practitioners to treat children under 18. Previously, only specialists could prescribe ADHD medicines, but now prescribing rules have been widened, removing prior restrictions and easing access to medication. These changes, along with removing renewal requirements for funded stimulant medicines, aim to connect more people with support earlier and positively impact education, employment, relationships, and mental health.
Tags: Matt Doocey ADHD New Zealand Medsafe Pharmac GPs nurse practitioners paediatrician psychiatrist Ministry of HealthNew Guidelines for Prescribing Psilocybin to Treat Depression Welcomed by Associate Health Minister
24 Jul 2025 | 1 year ago | 1934 viewsAssociate Health Minister David Seymour supports the publication of guidelines by Medsafe for prescribing Psilocybin to treat depression, aligning New Zealand with Australia. The guidelines require practitioners to meet specific criteria, including registration with the Medical Council and expertise in psychedelic-assisted therapy. Approval allows experienced psychiatrists to prescribe Psilocybin to patients with treatment-resistant depression, with the potential for more practitioners to follow suit, expanding access to this treatment option.
Tags: David Seymour Medsafe Psilocybin Depression New Zealand Australia Psychiatrist Medical Council Psychotherapeutic processes Guidelines